Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to $948,944.

  • bioAffinity Technologies' Shares Outstanding (Weighted Average) rose 86.16% to $948,944 in Q3 2025 from the same period last year, while for Sep 2025 it was $948,944, marking a year-over-year increase of 86.16%. This contributed to the annual value of $519,483 for FY2024, which is 64.01% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Shares Outstanding (Weighted Average) is $948,944, which was up 4.47% from $908,306 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Shares Outstanding (Weighted Average) high stood at $948,944 for Q3 2025, and its period low was $139,763 during Q1 2022.
  • For the 3-year period, bioAffinity Technologies' Shares Outstanding (Weighted Average) averaged around $490,017, with its median value being $388,581 (2024).
  • Data for bioAffinity Technologies' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 133.75% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Shares Outstanding (Weighted Average) stood at $278,989 in 2022, then rose by 13.53% to $316,738 in 2023, then spiked by 64.01% to $519,483 in 2024, then spiked by 86.16% to $948,944 in 2025.
  • Its Shares Outstanding (Weighted Average) was $948,944 in Q3 2025, compared to $908,306 in Q2 2025 and $608,521 in Q1 2025.